Back to All Events

Presbyopia-Correcting Eye Drop Therapy Across Eye Care: A Clinical Framework for Patient Selection, Screening, and Counseling

 
 

Join Woo U for a one-hour CE event focused on integrating presbyopia-correcting eye drop therapy into your practice. This session provides a practical clinical framework, covering evidence-based strategies for effective patient selection, screening, and counseling.

Our expert panel will review available clinical trial data, real-world safety evidence, prescribing information, and case-based patient-selection scenarios. The discussion will emphasize practical prescribing confidence, including how to identify appropriate candidates, when to defer therapy, when to refer for retinal evaluation, and how to counsel patients before initiating treatment.

Almost 1500 attended our event and we received amazing feedback!

Feedback from anonymous survey:

  • Excellent overview of the latest medication!

  • Loved the multi-practitioner approach!

  • Great lecture! I would like more lectures on genetic testing and how it can have an impact on optometry.

  • Thank you great speakers and well given CE.

  • I appreciated this topic very much, something new to offer patients.

  • Thank you for another informative webinar.

  • Enjoyed having multiple perspectives.

  • Great topic, hope have further information.

  • Very clear and concise information, with great examples for practical application. Great speakers.

  • Great education as reps presenting these drops rarely mention the potential negative retinal issues.

Faculty: Mile Brujic, O.D., Rishi Singh, M.D., and Jacob Lang, O.D.

Moderator: Mile Brujic, O.D.

COPE ID: 106413-PH

Category: Pharmacology

This event is COPE approved for 1 hour of CE credit.

This educational activity is supported with a medical education grant from Tenpoint Therapeutics in collaboration with iVista Medical Education, Inc.

Previous
Previous
September 9

Visual Fields: What’s Old, What’s New, What’s Out, What’s In

Next
Next
September 16

Phase Four: Filling the Gaps